NCT02337933View on ClinicalTrials.gov

Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Metabolic Syndrome X
Interventions
DRUG

Ursolic acid

Ursolic acid capsules of 150 mg extracted from rosemary, once a day before breakfast

DRUG

Placebo

Calcined magnesia capsules of 150 mg, once a day before breakfast

Trial Locations (1)

44140

Instituto de Terapéutica Experimental y Clínica, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02337933 - Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome | Biotech Hunter | Biotech Hunter